← Leaderboards
David Vanderweele
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Basic Sciences - Nci
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstatePathway InteractionsMalignant NeoplasmsAdvanced DiseaseMutationAndrogen ReceptorLocalized DiseaseXenograft ProcedureClinically RelevantInhibitor/AntagonistExome SequencingTargeted TreatmentDisease ResistanceBiologicalEvolutionPten GeneSignal PathwayHuman TissueCancer CellEffective TherapyInsightOrganoidsGenetically Engineered MouseMetastatic Prostate Cancer
Grant awards (10)
Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer$543,730
ZIA · FY2018 · CA · contact PI
Multiregion sequencing of localized prostate cancer$108,745
ZIA · FY2018 · CA · contact PI
Molecular characteristics of aggressive prostate cancer subtypes$36,249
ZIA · FY2018 · CA · contact PI
Development of therapy for aggressive variant prostate cancer$36,249
ZIA · FY2018 · CA · contact PI
Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer$645,742
ZIA · FY2017 · CA · contact PI
Multiregion sequencing of localized prostate cancer$129,149
ZIA · FY2017 · CA · contact PI
Development of therapy for aggressive variant prostate cancer$43,050
ZIA · FY2017 · CA · contact PI
Evolution of prostate cancer genome$43,050
ZIA · FY2017 · CA · contact PI
Mechanisms of resistance to Androgen Receptor inhibition in prostate cancer$690,899
ZIA · FY2016 · CA · contact PI
Multiregion sequencing of localized prostate cancer$36,363
ZIA · FY2016 · CA · contact PI